(Q41703047)

7 October 2017

Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas (English)

1 reference

7 October 2017

S Naftalovich

1

1 reference

7 October 2017

E Yefenof

series ordinal

2

1 reference

7 October 2017

Y Eilam

series ordinal

3

1 reference

7 October 2017

1 January 1991

1 reference

Cancer Chemotherapy and Pharmacology

7 October 2017

1 reference

7 October 2017

28

1 reference

7 October 2017

5

1 reference

7 October 2017

384-390

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00685694

7 October 2017

0 references

cites work

In vitro synergistic activity of ketoconazole with trifluoperazine and with chlorpromazine against medically important yeasts

1 reference

12 December 2020

Calmodulin and cell proliferation

1 reference

12 December 2020

Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma.

1 reference

12 December 2020

Gynecomastia with ketoconazole

1 reference

12 December 2020

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

1 reference

12 December 2020

Ketoconazole for prostate cancer

1 reference

12 December 2020

Ketoconazole Therapy in Advanced Prostatic Cancer

1 reference

12 December 2020

Ketoconazole inhibition and glucocorticoid action in the human lymphoblastic leukemia cell line CEM-C7.

1 reference

12 December 2020

Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary

1 reference

12 December 2020

In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis

1 reference

12 December 2020

Inhibition of cholesterol synthesis by ketoconazole

1 reference

12 December 2020

Non-chemotherapeutic agents that potentiate chemotherapy efficacy

1 reference

12 December 2020

Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin

1 reference

12 December 2020

In vivo toxicity of phenothiazines to cells of a transplantable tumor

1 reference

12 December 2020

Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment

1 reference

12 December 2020

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance

1 reference

12 December 2020

Regulation of intracellular levels of calmodulin and tubulin in normal and transformed cells

1 reference

12 December 2020

Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular do

1 reference

12 December 2020

Antigen non-specific activities in culture supernatant of ovalbumin-specific, cloned helper T lymphoma.

1 reference

12 December 2020

The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis

1 reference

12 December 2020

Ketoconazole for male metastatic breast cancer

1 reference

12 December 2020

Calmodulin is required for cell-cycle progression during G1 and mitosis

1 reference

12 December 2020

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

1 reference

12 December 2020

Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships

1 reference

12 December 2020

Low concentrations of trifluoperazine arrest the cell division cycle of Saccharomyces cerevisiae at two specific stages

1 reference

12 December 2020

Calmodulin and the cell cycle: involvement in regulation of cell-cycle progression

1 reference

12 December 2020

Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells

1 reference

12 December 2020

The effect of ketoconazole on adrenal and testicular steroidogenesis in vitro

1 reference

12 December 2020

Adrenal rest tumor of the liver causing Cushing's syndrome: treatment with ketoconazole preceding an apparent surgical cure

1 reference

12 December 2020

Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain

1 reference

12 December 2020

Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13

1 reference

12 December 2020

Calcium, calmodulin and cell proliferation

1 reference

12 December 2020

Cytotoxicity of ketoconazole in malignant cell lines

1 reference

12 December 2020

The effect of trifluoperazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in culture.

1 reference

12 December 2020

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer

1 reference

12 December 2020

Ketoconazole: A thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma

1 reference

12 December 2020

Selective cytotoxicity of calmidazolium and trifluoperazine for cycling versus noncycling C3H10T1/2 cells in vitro

1 reference

12 December 2020

Cations and calmodulin in normal and neoplastic cell growth regulation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685694

1 reference

Dimensions Publication ID

7 October 2017

0 references

1 reference